AAAAAA

   
Results: 1-12 |
Results: 12
TROPISETRON IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING OVER 6 COURSES OF EMETOGENIC CHEMOTHERAPY
Authors: BLEIBERG H HULSTAERT F BUYSE M DEKEYSER P
Citation: H. Bleiberg et al., TROPISETRON IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING OVER 6 COURSES OF EMETOGENIC CHEMOTHERAPY, Anti-cancer drugs, 9(9), 1998, pp. 773-777
12 WEEKS OF CONTINUOUS ORAL-THERAPY FOR TOENAIL ONYCHOMYCOSIS CAUSED BY DERMATOPHYTES - A DOUBLE-BLIND COMPARATIVE TRIAL OF TERBINAFINE 250MG DAY VERSUS ITRACONAZOLE 200 MG/DAY/
Authors: DEBACKER M DEVROEY C LESAFFRE E SCHEYS I DEKEYSER P
Citation: M. Debacker et al., 12 WEEKS OF CONTINUOUS ORAL-THERAPY FOR TOENAIL ONYCHOMYCOSIS CAUSED BY DERMATOPHYTES - A DOUBLE-BLIND COMPARATIVE TRIAL OF TERBINAFINE 250MG DAY VERSUS ITRACONAZOLE 200 MG/DAY/, Journal of the American Academy of Dermatology, 38(5), 1998, pp. 57-63
ACUTE BACTERIAL-MENINGITIS AFTER DENTAL FILLINGS
Authors: SHETTY N DEKEYSER P RIDGWAY GL
Citation: N. Shetty et al., ACUTE BACTERIAL-MENINGITIS AFTER DENTAL FILLINGS, The Journal of infection, 37(1), 1998, pp. 89-90
INTERDISCIPLINARY HEALTH-CARE AND FEMALE VICTIMS OF DOMESTIC VIOLENCE
Authors: SHIELDS G BAER J LEININGER K MARLOW J DEKEYSER P
Citation: G. Shields et al., INTERDISCIPLINARY HEALTH-CARE AND FEMALE VICTIMS OF DOMESTIC VIOLENCE, Social work in health care, 27(2), 1998, pp. 27-48
CONTROL OF NAUSEA AND VOMITING BY NAVOBAN(R) (TROPISETRON) IN 131 CHILDREN RECEIVING CYTOTOXIC CHEMOTHERAPY
Authors: BENOIT Y HULSTAERT F VERMYLEN C SARIBAN E HOYOUX C UYTTEBROECK A OTTEN J LAUREYS G DEKERPEL I NORTIER D RITTER L DEKEYSER P
Citation: Y. Benoit et al., CONTROL OF NAUSEA AND VOMITING BY NAVOBAN(R) (TROPISETRON) IN 131 CHILDREN RECEIVING CYTOTOXIC CHEMOTHERAPY, Anti-cancer drugs, 6, 1995, pp. 9-14
OPTIMAL COMBINATION THERAPY WITH NAVOBAN(R) (TROPISETRON) IN PATIENTSWITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: VANBELLE SJP COCQUYT VFJ BLEIBERG H CANON JL BUYSE M HULSTAERT F DEWITTE M DEKEYSER P WESTELINCK K
Citation: Sjp. Vanbelle et al., OPTIMAL COMBINATION THERAPY WITH NAVOBAN(R) (TROPISETRON) IN PATIENTSWITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Anti-cancer drugs, 6, 1995, pp. 22-30
THE USE OF SANDIMMUN(R) (CYCLOSPORINE-A) IN SEVERE REFRACTORY RHEUMATOID-ARTHRITIS - THE BELGIAN EXPERIENCE
Authors: MALAISE MG DEKEYSER P DEBACKER M VANLIERDE MA LESAFFRE E
Citation: Mg. Malaise et al., THE USE OF SANDIMMUN(R) (CYCLOSPORINE-A) IN SEVERE REFRACTORY RHEUMATOID-ARTHRITIS - THE BELGIAN EXPERIENCE, Clinical rheumatology, 14, 1995, pp. 26-32
TROPISETRON IN THE PREVENTION OF NAUSEA AND VOMITING IN 131 CHILDREN RECEIVING CYTOTOXIC CHEMOTHERAPY
Authors: BENOIT Y HULSTAERT F VERMYLEN C SARIBAN E HOYOUX C UYTTEBROECK A OTTEN J LAUREYS G DEKERPEL I NORTIER D RITTER L DEKEYSER P
Citation: Y. Benoit et al., TROPISETRON IN THE PREVENTION OF NAUSEA AND VOMITING IN 131 CHILDREN RECEIVING CYTOTOXIC CHEMOTHERAPY, Medical and pediatric oncology, 25(6), 1995, pp. 457-462
OPTIMAL COMBINATION THERAPY WITH TROPISETRON IN 445 PATIENTS WITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: HULSTAERT F VANBELLE S BLEIBERG H CANON JL DEWITTE M BUYSE M DEKEYSER P WESTELINCK KJ
Citation: F. Hulstaert et al., OPTIMAL COMBINATION THERAPY WITH TROPISETRON IN 445 PATIENTS WITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Journal of clinical oncology, 12(11), 1994, pp. 2439-2446
AT EQUIPOTENT DOSES, ISRADIPINE IS BETTER TOLERATED THAN AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION - A DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP STUDY
Authors: HERMANS L DEBLANDER A DEKEYSER P SCHEYS I LESAFFRE E WESTELINCK KJ
Citation: L. Hermans et al., AT EQUIPOTENT DOSES, ISRADIPINE IS BETTER TOLERATED THAN AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION - A DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP STUDY, British journal of clinical pharmacology, 38(4), 1994, pp. 335-340
2-WEEK ORAL TREATMENT OF TINEA-PEDIS, COMPARING TERBINAFINE (250 MG DAY) WITH ITRACONAZOLE (100 MG/DAY) - A DOUBLE-BLIND, MULTICENTER STUDY/
Authors: DEKEYSER P DEBACKER M MASSART DL WESTELINCK KJ
Citation: P. Dekeyser et al., 2-WEEK ORAL TREATMENT OF TINEA-PEDIS, COMPARING TERBINAFINE (250 MG DAY) WITH ITRACONAZOLE (100 MG/DAY) - A DOUBLE-BLIND, MULTICENTER STUDY/, British journal of dermatology, 130, 1994, pp. 22-25
VISCOELASTIC AND TRANSIENT NETWORK PROPERTIES OF HYALURONIC-ACID AS AFUNCTION OF THE CONCENTRATION
Authors: DESMEDT SC DEKEYSER P RIBITSCH V LAUWERS A DEMEESTER J
Citation: Sc. Desmedt et al., VISCOELASTIC AND TRANSIENT NETWORK PROPERTIES OF HYALURONIC-ACID AS AFUNCTION OF THE CONCENTRATION, Biorheology, 30(1), 1993, pp. 31-41
Risultati: 1-12 |